(Q46706686)

English

Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome

scientific article published in March 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18335328

Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18335328

0 references

0 references

polycystic ovary syndrome

1 reference

based on heuristic

inferred from title

polycystic ovary

1 reference

based on heuristic

inferred from title

Alessandro D Genazzani

object named as

Alessandro D Genazzani

1

0 references

author name string

Chiara Lanzoni

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18335328

Federica Ricchieri

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18335328

Valerio M Jasonni

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18335328

publication date

1 March 2008

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18335328

Gynecological Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18335328

24

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18335328

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18335328

139-144

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18335328

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893232

21 January 2018

Insulin sensitizers for polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893232

21 January 2018

Metformin administration modulates and restores luteinizing hormone spontaneous episodic secretion and ovarian function in nonobese patients with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893232

21 January 2018

Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893232

21 January 2018

Insulin-Lowering Agents in the Management of Polycystic Ovary Syndrome

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893232

21 January 2018

Impact of insulin and body mass index on metabolic and endocrine variables in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893232

21 January 2018

Second messengers of insulin action

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893232

21 January 2018

Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893232

21 January 2018

chiro-inositol deficiency and insulin resistance: a comparison of the chiro-inositol- and the myo-inositol-containing insulin mediators isolated from urine, hemodialysate, and muscle of control and type II diabetic subjects

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893232

21 January 2018

Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893232

21 January 2018

Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893232

21 January 2018

Altered D-chiro-inositol urinary clearance in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893232

21 January 2018

Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893232

21 January 2018

Effects of myo-inositol on the in-vitro maturation and subsequent development of mouse oocytes

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893232

21 January 2018

The homeostasis model in the San Antonio Heart Study.

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893232

21 January 2018

Luteinizing hormone (LH) secretory burst duration is independent from LH, prolactin, or gonadal steroid plasma levels in amenorrheic women.

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893232

21 January 2018

Myo-inositol and prostaglandins reverse the glucose inhibition of neural tube fusion in cultured mouse embryos

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893232

21 January 2018

Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893232

21 January 2018

Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893232

21 January 2018

The importance of diagnosing the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893232

21 January 2018

Effect of troglitazone on endocrine and ovulatory performance in women with insulin resistance-related polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893232

21 January 2018

High ovulatory rates with use of troglitazone in clomiphene-resistant women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893232

21 January 2018

A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893232

21 January 2018

Insulin-signaling mechanisms. Lessons from the old testament of glycogen metabolism and the new testament of molecular biology

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893232

21 January 2018

Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia

1 reference

https://api.crossref.org/works/10.1080%2F09513590801893232

21 January 2018

Identifiers

10.1080/09513590801893232

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18335328

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18335328

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46706686&oldid=2127647914"